GlassScriptPhysician profile
Igor Porotov
NPI 1306945613
$1,111.00
in general payments reported to CMS, 2019-2025
16 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $154 · 2021: $55.89 · 2023: $43.82 · 2024: $98.88 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $396.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $186.37 | 2019-2020 | |
| Biogen, INC. | $174.95 | 2019-2023 | Vumerity |
| Abbvie INC. | $153.01 | 2023-2025 | |
| Genzyme Corporation | $149.71 | 2019-2020 | |
| Argenx US, INC. | $138.62 | 2024-2025 | Vyvgart, Vyvgart Hytrulo |
| Csl Behring | $79.87 | 2019 | |
| Amgen INC. | $39.14 | 2025 | Uplizna |
| Acorda Therapeutics, INC | $34.75 | 2019 | |
| Lilly USA, LLC | $26.11 | 2019 | |
| Ucb, INC. | $23.90 | 2019 | |
| Sk Life Science, INC. | $23.46 | 2024 | |
| Allergan, INC. | $18.97 | 2021 | |
| Amneal Pharmaceuticals LLC | $17.59 | 2024 | Ongentys 50mg Capsules 30 |
| Novartis Pharmaceuticals Corporation | $15.55 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $14.84 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $14.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Igor Porotov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.